4.3 Review

ROS-induced cell cycle arrest as a mechanism of resistance in polyaneuploid cancer cells (PACCs)

Journal

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
Volume 165, Issue -, Pages 3-7

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pbiomolbio.2021.05.002

Keywords

Polyploid giant cancer cell (PGCC); Polyaneuploid cancer cell (PACC); Reactive oxygen species; Cell cycle; Therapy resistance

Funding

  1. US Department of Defense CDMRP/PCRP [W81XWH-20-10353]
  2. Patrick C. Walsh Prostate Cancer Research Fund
  3. Prostate Cancer Foundation
  4. NCI [U54CA143803, CA163124, CA093900, CA143055]
  5. William and Carolyn Stutt Research Fund
  6. Ronald Rose
  7. MC Dean, Inc.
  8. William and Marjorie Springer
  9. Mary and Dave Stevens
  10. Louis Dorfman
  11. Jones Family Foundation
  12. Timothy Hanson
  13. David and June Trone Family Foundation

Ask authors/readers for more resources

Cancer cells respond to oxidative stress by activating the DNA damage response and entering cell cycle arrest, leading to apoptosis in most cases, but some cells may enter a protected G0 state and become polyaneuploid cancer cells, resulting in resistant tumor growth.
Cancer is responsible for the deaths of millions of people worldwide each year. Once metastasized, the disease is incurable and shows resistance to all anti-cancer therapies. The already-elevated level of reactive oxygen species (ROS) in cancer cells is further increased by therapies. The oxidative stress activates the DNA damage response (DDR) and the stressed cancer cell moves towards cell cycle arrest. Once arrested, the majority of cancer cells will undergo programmed cell death in the form of apoptosis. If the cancer cell is able to exit the cell cycle prior to cell division and enter a protected G0 state, it is able to withstand and survive therapy as a polyaneuploid cancer cell (PACC) and eventually seed resistant tumor growth. (c) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available